Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Fresenius Medical Care Deutschland clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Germany and Czechia registers with Fresenius Medical Care Deutschland as lead sponsor. Synced 13 Nov 2026
6Current trials
4Recruiting now
0Drugs in these trials
2Trial registers
At a glance

Fresenius Medical Care Deutschland is the lead sponsor of 6 current clinical trials in our Germany and Czechia registers. 4 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Autoimmune Diseases.

Company profile on this site (news, sites, medicines, approvals): Fresenius SE (DE) →

ClinicalTrials.gov trials by status

  • Recruiting467%
  • Not yet open117%
  • Active, closed117%

Trials by phase

  • Not applicable350%
  • Observational350%
01

Clinical trials sponsored by Fresenius Medical Care Deutschland

6 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Comparison of Individualized Sodium Management Versus Standard Treatment in Hemodialysis
NCT06341452 · ClinicalTrials.gov ↗ · End Stage Renal Disease
Not applicable Recruiting 2025-12 Czechia
Analysis of Paediatric Treatments With multiFiltratePRO
NCT06603324 · ClinicalTrials.gov ↗ · Renal Failure, CVVHD
Not applicable Recruiting 2025-10 Germany, Czechia
Clinical Performance of the New Plasma Filter PX2 in TPE Treatments
NCT06382675 · ClinicalTrials.gov ↗ · Autoimmune Diseases
Not applicable Recruiting 2024-07 Germany
PD Catheter Data Collection
NCT07156123 · ClinicalTrials.gov ↗ · Renal Insufficiency / Therapy
Observational Recruiting 2026-07 Germany
Analysis of Continuous Kidney Replacement Therapy (CKRT) Treatments With multiFlux Hemofilters Using Regional Citrate Anticoagulation (RCA) or Systemic Heparin Anticoagulation
NCT07679568 · ClinicalTrials.gov ↗ · Acute Kidney Injury, Renal Failure
Observational Not yet open 2026-11 Germany
Analysis of TPE Treatments With multiFiltratePRO
NCT06272084 · ClinicalTrials.gov ↗ · Autoimmune Diseases
Observational Active, closed 2024-05 Germany

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Fresenius Medical Care Deutschland trials

6 conditions
Autoimmune Diseases2Renal Failure2Renal Insufficiency / Therapy1Acute Kidney Injury1CVVHD1End Stage Renal Disease1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Germany53
Clinical trials in Czechia22

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Autoimmune Diseases

SponsorTrials
The Children's Hospital of Zhejiang University School of Medicine6
Kite, A Gilead Company2
Imagine Institute2
Adicet Therapeutics1
Groupe français d'étude des Maladies Inflammatoires de loeil1
Myeloid Therapeutics1
Seismic Therapeutic AU1

Sponsors with the most current trials registered for this condition.

05

Questions about Fresenius Medical Care Deutschland trials

How many clinical trials does Fresenius Medical Care Deutschland sponsor?

Fresenius Medical Care Deutschland is the lead sponsor of 6 current trials on ClinicalTrials.gov in our Germany and Czechia registers, as of the registry sync on 13 November 2026. Completed and withdrawn studies are not counted.

Are Fresenius Medical Care Deutschland trials recruiting?

Yes. 4 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 13 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.